| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/02/2001 | CN1293248A Human shear and adenylation specific factor protein and its coding sequence |
| 05/02/2001 | CN1293247A Human zinc finger protein and its coding sequence |
| 05/02/2001 | CN1293246A Polypeptide-human calcium ion protein 48 for regulating secretion and polynucleotide for coding this polypeptide |
| 05/02/2001 | CN1293207A Fusion protein with improved combining activity to target cell receptor |
| 05/02/2001 | CN1293204A Polypeptide-human bromo-functional protein 72 and polynucleotide for coding this polypeptide |
| 05/02/2001 | CN1293203A Polypeptide-human zinc finger protein 59 and polynucleotide for coding this polypeptide |
| 05/02/2001 | CN1065278C Method for preparation of 7-amino cephaloalkyl acid by one step and two enzyme method |
| 05/02/2001 | CN1065276C Human interleukin-2 immunotoxin |
| 05/02/2001 | CN1065142C Composition used as therapeutic agent against chronic viral hepatic diseases |
| 05/01/2001 | US6225536 Nucleotide sequences from preferential ovules or fibers of plants; for the generation of plants with amplified fiber length, fineness and strength |
| 05/01/2001 | US6225532 Nucleotide sequences which code a protein which prevents parasite infection of plant cells |
| 05/01/2001 | US6225531 Glucan elicitor receptor, DNA molecule coding therefor, fungus-resistant plants transformed with the DNA molecule and method for creating the plants |
| 05/01/2001 | US6225530 Flowering locus T (FT) and genetically modified plants having modulated flower development |
| 05/01/2001 | US6225529 Seed-preferred promoters |
| 05/01/2001 | US6225528 Method of making pathogen-resistant plants by transformation with a fatty acid desaturase gene |
| 05/01/2001 | US6225527 Nucleotide sequences associated with response to parasite infection; for the prevention of parasite infection; for the development of disease resistant plants |
| 05/01/2001 | US6225526 Particularly from spinacia oleracea; transgenic plant cell |
| 05/01/2001 | US6225525 ATP-binding cassette transporter (ABC1) modified transgenic mice |
| 05/01/2001 | US6225459 Nucleotide sequences for the expression of heterologous genes; for the treatment of genetic disorders |
| 05/01/2001 | US6225457 Polynucleotide sequences associated with bacterial proteins; for detection of bactericides |
| 05/01/2001 | US6225455 Constructs for producing phosphorylated fusion proteins |
| 05/01/2001 | US6225454 Nucleotide sequences coding enzymatic protein; for use in gene therapy |
| 05/01/2001 | US6225453 Nucleootide sequences for the detection of bacterial infections |
| 05/01/2001 | US6225450 Intact positively charged ionized mass-modified nucleic acid molecule |
| 05/01/2001 | US6225449 Hormone analogs with multiple CTP extensions |
| 05/01/2001 | US6225448 1gG /transferrin receptor fusion protein |
| 05/01/2001 | US6225447 Methods for producing members of specific binding pairs |
| 05/01/2001 | US6225444 Bind calcium and which are useful in treating stroke and other neurodegenerative diseases |
| 05/01/2001 | US6225441 Forkhead activin signal transducer polypetide; for screening modulators of transforming growth factors |
| 05/01/2001 | US6225292 Inhibitors of DNA immunostimulatory sequence activity |
| 05/01/2001 | US6225291 Rod opsin mRNA-specific ribozyme compositions and methods for the treatment of retinal diseases |
| 05/01/2001 | US6225290 Provides advantages:short term or long term cures and/or treatment, avoids invasive procedures, oral administration, naked dna is used rather than viral vectors, side-effects of long term gene administration can be avoided |
| 05/01/2001 | US6225289 Methods and compositions for preserving adenoviral vectors |
| 05/01/2001 | US6225286 Cell surface protein expressed on human cortical thymocyte and their use |
| 05/01/2001 | US6225285 Semaphorin K1 |
| 05/01/2001 | US6225131 Apparatus for the detection of preferential compounds in sample |
| 05/01/2001 | US6225122 Generating immortalized neuronal cells; transfecting cells, propagating on preferential nutrients and detecting transfected cells of interest |
| 05/01/2001 | US6225121 Eukaryotic transposable element |
| 05/01/2001 | US6225115 DNA encoding taurine and GABA transporters and uses thereof |
| 05/01/2001 | US6225114 Modified gene encoding glyphosate-tolerant 5-enolpruvyl-3-phosphoshikimate synthase |
| 05/01/2001 | US6225113 Genetically engineered vector for the transcription of heterologous genes in cells |
| 05/01/2001 | US6225112 Human p27Kip1 gene promoter |
| 05/01/2001 | US6225111 Expression vector for the expression of heterologous proteins |
| 05/01/2001 | US6225109 Apparatus for the detection of nucleotide sequences; for the detection of restriction fragment length polymorphisms in humans; for monitoring antibiotic resistance in bacteria |
| 05/01/2001 | US6225106 Nucleotide sequences coding microorganism kinase; for the efficient expression of heterologous proteins |
| 05/01/2001 | US6225105 Mutant acetolactate synthase gene from Arabidopsis thaliana for conferring imidazolinone resistance to crop plants |
| 05/01/2001 | US6225103 Protease for use as diagnostic indicator of cancer |
| 05/01/2001 | US6225102 Amino acid sequence of guanosine triphosphatase from streptococcus; diagnosis; prophylaxis; drug screening; bactericides; bacteriostats |
| 05/01/2001 | US6225099 Alcohol dehydrogenase and its use for the enzymatic production of chiral hydroxy compounds |
| 05/01/2001 | US6225098 UDP-N-acetylenolpyruvyglucosamine reductase |
| 05/01/2001 | US6225096 Mutant prenyl diphosphate synthase, DNA encoding mutant prenyl diphosphate synthase and process for producing mutant prenyl phosphate synthase |
| 05/01/2001 | US6225092 One step, one pot process using a second thermostable dna polymerase which has a reduced ability to incorporate dideoxynucleotides |
| 05/01/2001 | US6225091 Multimeric hybrid gene encoding a chimeric protein which confers protection against parainfluenza virus and respiratory synctial virus |
| 05/01/2001 | US6225090 Compounds |
| 05/01/2001 | US6225089 Nucleotide and amino acid sequence of transport protein; for culture production of p-hydroxybenzoic acid |
| 05/01/2001 | US6225088 DNA encoding plasminogen-like growth factor (PLGF) and related embodiments |
| 05/01/2001 | US6225087 Polynucleotide which codes for a polypeptide of defined amino acid sequence; drug screening of bactericides against streptococcus; otitis media; conjunctivitis; pneumonia; meningitis; sinusitis; pleural empyema; endocarditis |
| 05/01/2001 | US6225085 Nucleotide and amino acid sequence of leucine-rich surface glycoprotein; diagnosis; prophylaxis; therapy; drug screening; fusion proteins; antigenic peptides; antibodies; recombinant production |
| 05/01/2001 | US6225084 Nucleotide and amion acid sequence of genes that are up-regulated in endothelial cells subjected to shear stress; atherosclerosis, antiischemic agents; hypotensive agents; restenosis; antiinflammatory agents for arteries |
| 05/01/2001 | US6225083 Nucleotide and amino acid sequences of membrane protein involved in cell division; drug screening; bactericides; bacteriostats; antibiotics; for meningitis, sinusitis, conjunctivitis, otitis media, and endocarditis |
| 05/01/2001 | US6225082 Nucleic acid which is cis-acting messenger rna transport sequence; expression vectors; gene therapy |
| 05/01/2001 | US6225081 Protein, DNA coding for same and method of producing the protein |
| 05/01/2001 | US6225077 Method for characterizing DNA sequences |
| 05/01/2001 | US6225073 Immunoassay for mycophenolic acid |
| 05/01/2001 | US6225067 Methods and devices for performing analysis of a nucleic acid sample |
| 05/01/2001 | US6225066 Determining drug resistance by incubating strain with drug and temperate mycobacteriophage permiting formation of lysogens which express reporter gene, then detecting transcription of reporter gene as indicator of resistance |
| 05/01/2001 | US6225064 Ligating oligonucleotides to 3' termini of sample dna fragment groups, mixing ligated products together, amplifying using polymerase chain reaction and primers complementary to oligonucleotides, and detecting; comparison of plural samples |
| 05/01/2001 | US6225063 RNA channels in biological membranes |
| 05/01/2001 | US6225060 Includes selectable marker gene, promoter, transcription termination sequence, nucleotide sequence that encodes a tag, and a cloning site; for determining function of foreign genetic material by transfection into a host |
| 05/01/2001 | US6225057 Duplications of human chromosome 15q24-25 and anxiety disorders, diagnostic methods for their detection |
| 05/01/2001 | US6225055 Apparatus for the parallel alignment of macromolecules, and use thereof |
| 05/01/2001 | US6225054 Compositions and methods for the treatment and diagnosis of breast cancer |
| 05/01/2001 | US6225048 Culturing monocytes in fluid communication with viable, allogenically stimulated peripheral blood mononuclear cells to cause differentiation into macrophages, then permitting replication of latent or exogenous virus |
| 05/01/2001 | US6225047 Use of retentate chromatography to generate difference maps |
| 05/01/2001 | US6225044 Method for gene transfer into cells activated from a quiescent state |
| 05/01/2001 | US6225042 Culturing genetically engineered, antigen presenting insect cell line so that major histocompatibility class i molecules bound to selected peptide are produced on surface of cell, then contacting with cd8 t cells |
| 05/01/2001 | US6224881 DNA molecule fragments encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof |
| 05/01/2001 | US6224879 Genetic engineering |
| 05/01/2001 | US6224878 Culture product; genetic engineering |
| 05/01/2001 | US6224869 Isolated polypeptide |
| 05/01/2001 | US6224868 Reagent and processes for targeting mutant epidermal growth factor receptors |
| 05/01/2001 | US6224858 Hepatocytes transduced with a retroviral vector comprising splice sites and methods of expression |
| 05/01/2001 | CA2324651A1 Split spool type flexible coupling |
| 05/01/2001 | CA2286301A1 The filamentous phage as a multivalent scaffold for coupling synthetic peptides for immunization |
| 05/01/2001 | CA2210875C Cationic copolymers of vinylamine and vinyl alcohol for the delivery of oligonucleotides |
| 05/01/2001 | CA2067333C Production of genetically-engineered vaccines for aids and retroviral diseases |
| 05/01/2001 | CA2046303C Il-1 biological activity inhibitors |
| 05/01/2001 | CA1341226C Gene replacement as a tool for the construction of aspergillus strains |
| 05/01/2001 | CA1341223C Dna clone of human tissue factor inhibitor |
| 05/01/2001 | CA1341220C Cloning and characterization of the bovine interleukin-2-gene |
| 05/01/2001 | CA1341219C Site specific mutagenesis in alpha-1-antitrypsin |
| 04/29/2001 | CA2322903A1 Treatment, diagnosis and evaluation of anti-cancer therapy resistance in melanoma |
| 04/29/2001 | CA2322751A1 Analysis and prediction of protein functional subtypes from protein sequence alignments |
| 04/29/2001 | CA2321976A1 Retroviral vector for delivering a nucleotide sequence encoding a cellular gap junction protein |
| 04/29/2001 | CA2286401A1 Methods of diagnosing and treating melanoma utilizing tyrp2 |
| 04/28/2001 | CA2322553A1 Novel nucleotide sequences coding for the poxb gene |
| 04/27/2001 | CA2321975A1 Nucleotide sequences coding for the export of branched-chain amino acids, process for the isolation thereof and use thereof |
| 04/27/2001 | CA2286515A1 Constitutive expression of plant genes by a 648 bp regulatory sequence from a pea polyubiquitin gene |
| 04/26/2001 | WO2001029564A1 Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies |
| 04/26/2001 | WO2001029563A1 Method of screening for inhibitors of asp2 |